Why is Bliss GVS Pharma falling/rising?

As of 10-Nov, Bliss GVS Pharma Ltd's stock price is currently at 147.95, reflecting an increase of 19.85, or 15.5%. Today's price summary indicates that the stock has outperformed its sector by 14.45% and has experienced a trend reversal after four consecutive days of decline. The stock reached an intraday high of Rs 151.75, showcasing significant volatility with an intraday range of Rs 33.4. Over the past year, the stock has generated a return of 19.75%, which is considerably higher than the market average, although it has seen a decline of 10.14% year-to-date. The company maintains a low debt-to-equity ratio and a fair valuation compared to its peers, but it faces challenges with poor long-term growth metrics and a decrease in institutional investor participation. In the broader market context, the stock's short-term performance has been negative, with a 1-week return of -4.55%, while the Sensex has only declined by 0.53% during the same period. This indicates that Bliss GVS Pharma has underperformed relative to the benchmark in the short term. Despite the recent rise in stock price, the overall market sentiment may be influenced by the company's flat results and declining institutional interest, which could weigh on future performance. The contrasting performance metrics highlight the stock's volatility and the mixed signals investors are receiving regarding its long-term growth potential.